Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis

Thierry Q. Mentzel; Rene van der Snoek; Ritsaert Lieverse; Margreet Oorschot; Wolfgang Viechtbauer; Oswald Bloemen; Peter N. van Harten

doi:10.4088/JCP.17r11852

Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis

Thierry Q. Mentzel^*, Rene van der Snoek, Ritsaert Lieverse, Margreet Oorschot, Wolfgang Viechtbauer, Oswald Bloemen, Peter N. van Harten

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	ARTN 17r11852
Number of pages	9
Journal	Journal of Clinical Psychiatry
Volume	79
Issue number	6
DOIs	https://doi.org/10.4088/JCP.17r11852
Publication status	Published - 2018

Keywords

RANDOMIZED CONTROLLED-TRIAL
QUALITY-OF-LIFE
TREATMENT-RESISTANT
DOUBLE-BLIND
2ND-GENERATION ANTIPSYCHOTICS
SCHIZOPHRENIC-PATIENTS
OLANZAPINE
DRUGS
DEUTETRABENAZINE
HALOPERIDOL

Cite this

Mentzel, T. Q., van der Snoek, R., Lieverse, R., Oorschot, M., Viechtbauer, W., Bloemen, O., & van Harten, P. N. (2018). Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis. Journal of Clinical Psychiatry, 79(6), [ARTN 17r11852]. https://doi.org/10.4088/JCP.17r11852

@article{1f890500088c40cebbaeb3a253a9c4a8,

title = "Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis",

keywords = "RANDOMIZED CONTROLLED-TRIAL, QUALITY-OF-LIFE, TREATMENT-RESISTANT, DOUBLE-BLIND, 2ND-GENERATION ANTIPSYCHOTICS, SCHIZOPHRENIC-PATIENTS, OLANZAPINE, DRUGS, DEUTETRABENAZINE, HALOPERIDOL",

author = "Mentzel, {Thierry Q.} and {van der Snoek}, Rene and Ritsaert Lieverse and Margreet Oorschot and Wolfgang Viechtbauer and Oswald Bloemen and {van Harten}, {Peter N.}",

year = "2018",

doi = "10.4088/JCP.17r11852",

language = "English",

volume = "79",

journal = "Journal of Clinical Psychiatry",

issn = "0160-6689",

publisher = "Physicians Postgraduate Press Inc.",

number = "6",

}

Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia : A Meta-Analysis. / Mentzel, Thierry Q.; van der Snoek, Rene; Lieverse, Ritsaert; Oorschot, Margreet; Viechtbauer, Wolfgang; Bloemen, Oswald; van Harten, Peter N.

In: Journal of Clinical Psychiatry, Vol. 79, No. 6, ARTN 17r11852, 2018.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia

T2 - A Meta-Analysis

AU - Mentzel, Thierry Q.

AU - van der Snoek, Rene

AU - Lieverse, Ritsaert

AU - Oorschot, Margreet

AU - Viechtbauer, Wolfgang

AU - Bloemen, Oswald

AU - van Harten, Peter N.

PY - 2018

Y1 - 2018

KW - RANDOMIZED CONTROLLED-TRIAL

KW - QUALITY-OF-LIFE

KW - TREATMENT-RESISTANT

KW - DOUBLE-BLIND

KW - 2ND-GENERATION ANTIPSYCHOTICS

KW - SCHIZOPHRENIC-PATIENTS

KW - OLANZAPINE

KW - DRUGS

KW - DEUTETRABENAZINE

KW - HALOPERIDOL

U2 - 10.4088/JCP.17r11852

DO - 10.4088/JCP.17r11852

M3 - Article

VL - 79

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 6

M1 - ARTN 17r11852

ER -

Access to Document

10.4088/JCP.17r11852